FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to urology and oncology. In order to diagnose stage of urinary bladder cancer invasion UBC-antigen of urinary bladder cancer, representing soluble fragment of cytokeratins 8 and 18, is determined in patient's urine. If its value is higher than 22.5 mcg/ml, TPS-tissue polypeptide spherical, which represents fragment of cytokeratin 18, is determined in blood serum. If TPS value is 61.5-106.93 Units/l, muscular-non-invasive urinary bladder cancer is diagnosed. If TPS value is 106.94-181.29 Units/l, invasive urinary bladder cancer within the organ is diagnosed. If TPS value is higher than 181.29 Units/l, outlet of tumour beyond the organ is diagnosed.
EFFECT: method makes it possible to diagnose stages of urinary bladder cancer invasion with high accuracy.
3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF BLADDER CANCER INVASION STAGE | 2007 |
|
RU2332168C1 |
| METHOD FOR DETECTING PERIVESICAL FIBRE INVASION IN BLADDER CANCER USING DYNAMIC MAGNETIC RESONANCE CYSTOGRAPHY | 2017 |
|
RU2688310C1 |
| METHOD FOR PREDICTING RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER | 2022 |
|
RU2793510C1 |
| METHOD FOR PREDICTICTION OF EARLY RECURRENCE OF SUPERFICIAL BLADDER CANCER | 2016 |
|
RU2635534C1 |
| METHOD OF ESTIMATION OF CLINICAL EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY OF BLADDER CANCER | 2009 |
|
RU2405157C1 |
| METHOD OF PREDICTING DEVELOPMENT OF RECURRENT INVASIVE URINARY BLADDER CANCER | 2009 |
|
RU2393772C1 |
| METHOD FOR ENDOSCOPIC TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER | 2014 |
|
RU2556612C1 |
| METHOD OF EVALUATING EFFICIENCY OF INTRAMURAL AUTOPLASMOCHEMICAL THERAPY OF URINE BLADDER CANCER | 2009 |
|
RU2398517C1 |
| METHOD OF COMPLEX TREATMENT AND PREVENTION OF RECURRENCES OF MUSCULAR-NON-INVASIVE FORMS OF URINARY BLADDER CANCER | 2013 |
|
RU2560314C2 |
| METHOD FOR DIAGNOSING URINARY BLADDER NEOPLASMS | 2002 |
|
RU2202954C1 |
